Nom du produit:Imidazo[1,2-a]quinoxalin-4(5H)-one

IUPAC Name:4H,5H-imidazo[1,2-a]quinoxalin-4-one

CAS:133307-45-6
Formule moléculaire:C10H7N3O
Pureté:95%
Numéro de catalogue:CM221164
Poids moléculaire:185.19

Unité d'emballage Stock disponible Prix($) Quantité
CM221164-1g 1-2 Weeks ǜNJƦ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:133307-45-6
Formule moléculaire:C10H7N3O
Point de fusion:-
Code SMILES:O=C1C2=NC=CN2C3=C(C=CC=C3)N1
Densité:
Numéro de catalogue:CM221164
Poids moléculaire:185.19
Point d'ébullition:
N° Mdl:MFCD00896828
Stockage:

Category Infos

Quinoxalines
Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.
Imidazopyrazines
In addition to the nitrogen-based heterocycles presented so far, a number of others nitrogen-based scaffolds have also been reported as promising agents for GBM treatment, including pyrazolo-triazole, imidazotetrazine, piperidine, purine, imidazopyrazine, pyrazole, triazole among others.